Evan Rosenbaum

Also affiliated with Regeneron (United States), Cornell University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors”.

Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3909

N/A

0.627DataRank · unranked

16 citations

Li‐Xuan Qin, Niedzica Camacho, Ciara M. Kelly, Sandra P. D’Angelo, Mark A. Dickson +19 more

HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0832

N/A

0DataRank · unranked

26 citations

Kenneth Seier, Chaitanya Bandlamudi, Mark A. Dickson, Mrinal M. Gounder, Mary Lou Keohan +12 more

The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breast

Histopathology(2021)10.1111/his.14433

N/A

0DataRank · unranked

25 citations

Bin Xu, Sandra P. D’Angelo, Evan Rosenbaum, George Plitas, Dara S. Ross +3 more

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Nature Communications(2022)10.1038/s41467-022-30453-x

N/A

0DataRank · unranked

215 citations

Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi +42 more

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004149

N/A

0DataRank · unranked

58 citations

Cristina R. Antonescu, Shaleigh Smith, Martina Bradić, Daniel Kashani, Allison L. Richards +17 more

A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3911

N/A

0DataRank · unranked

69 citations

Li‐Xuan Qin, Karissa Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan +18 more

Stereotactic body radiation therapy for sarcoma pulmonary metastases

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.109824

N/A

0DataRank · unranked

16 citations

Stephanie Lobaugh, Zhigang Zhang, Mark A. Dickson, Evan Rosenbaum, Sandra P. D’Angelo +12 more

Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0140

N/A

0DataRank · unranked

11 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11590

N/A

0DataRank · unranked

3 citations

Evan Rosenbaum, Rodrigo Gularte Mérida, Mark A. Dickson, Mary Louise Keohan, Mrinal M. Gounder +15 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242.v1

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2519

N/A

0DataRank · unranked

20 citations

Kenneth Seier, Viswatej Avutu, Lauren B. Banks, Jason E. Chan, Ping Chi +20 more

Clinicopathologic and molecular correlates to neoadjuvant chemotherapy‐induced pathologic response in breast angiosarcoma

Genes Chromosomes and Cancer(2024)10.1002/gcc.23240

N/A

0DataRank · unranked

6 citations

Josephine K. Dermawan, M. Gabriela Kuba, Aimeé M. Crago, Samuel Singer, William D. Tap +5 more

1762P Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1853

N/A

0DataRank · unranked

0 citations

Martina Bradić, Sara Saunds, V. Avutu, Jason W. Chan, Sandra P. D’Angelo +15 more

High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012357

N/A

0DataRank · unranked

1 citations

Martina Bradić, Hyung Jun Woo, Allison L. Richards, Ciara M. Kelly, Mark A. Dickson +17 more

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3959

N/A

0DataRank · unranked

119 citations

Shweta S. Chavan, David B. Solit, Rajmohan Murali, Robert A. Soslow, Sarah Chiang +9 more

Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade

npj Precision Oncology(2025)10.1038/s41698-025-00878-w

N/A

0DataRank · unranked

2 citations

Sara Coca Membribes, Cristina Anthonescu, Martina Bradić, Bernard O’Malley, Irina Linkov +9 more